Your browser doesn't support javascript.
loading
N6-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors.
Gao, Zhishuang; Li, Chao; Sun, Haoyu; Bian, Yibo; Cui, Zhiwei; Wang, Nuofan; Wang, Zhangjie; Yang, Yang; Liu, Zonghang; He, Zhongyuan; Li, Bowen; Li, Fengyuan; Li, Zheng; Wang, Linjun; Zhang, Diancai; Yang, Li; Xu, Zekuan; Li, Xueming; Xu, Hao.
Afiliação
  • Gao Z; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
  • Li C; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, 211166, Nanjing, China.
  • Sun H; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
  • Bian Y; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, 211166, Nanjing, China.
  • Cui Z; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
  • Wang N; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, 211166, Nanjing, China.
  • Wang Z; Department of Oncology, the Second Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
  • Yang Y; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
  • Liu Z; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, 211166, Nanjing, China.
  • He Z; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
  • Li B; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, 211166, Nanjing, China.
  • Li F; Department of Neurosurgery, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
  • Li Z; Institute of Digestive Endoscopy and Medical Center for Digestive Diseases, Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, Jiangsu, China.
  • Wang L; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
  • Zhang D; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, 211166, Nanjing, China.
  • Yang L; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
  • Xu Z; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, 211166, Nanjing, China.
  • Li X; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, China.
  • Xu H; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medical University, 211166, Nanjing, China.
Cell Death Differ ; 30(2): 544-559, 2023 02.
Article em En | MEDLINE | ID: mdl-36528756
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumores do Estroma Gastrointestinal Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article